Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 55

1.

Pentosan Polysulfate to control hepcidin expression in vitro and in vivo.

Asperti M, Denardo A, Gryzik M, Castagna A, Girelli D, Naggi A, Arosio P, Poli M.

Biochem Pharmacol. 2020 Feb 20:113867. doi: 10.1016/j.bcp.2020.113867. [Epub ahead of print]

PMID:
32088260
2.

Cellular binding analysis of recombinant hybrid heteropolymer of camel hepcidin and human ferritin H chain. The unexpected human H-ferritin binding to J774 murine macrophage cells.

Boumaiza M, Poli M, Carmona F, Asperti M, Gianoncelli A, Bertuzzi M, Arosio P, Marzouki MN.

Mol Biol Rep. 2020 Feb;47(2):1265-1273. doi: 10.1007/s11033-019-05234-3. Epub 2019 Dec 14.

PMID:
31838658
3.

Iron as Therapeutic Target in Human Diseases.

Gozzelino R, Poli M, Arosio P.

Pharmaceuticals (Basel). 2019 Dec 5;12(4). pii: E178. doi: 10.3390/ph12040178.

4.

α-Synuclein in blood cells differentiates Parkinson's disease from healthy controls.

Abd Elhadi S, Grigoletto J, Poli M, Arosio P, Arkadir D, Sharon R.

Ann Clin Transl Neurol. 2019 Dec;6(12):2426-2436. doi: 10.1002/acn3.50944. Epub 2019 Nov 19.

5.

Mutant L-chain ferritins that cause neuroferritinopathy alter ferritin functionality and iron permeability.

McNally JR, Mehlenbacher MR, Luscieti S, Smith GL, Reutovich AA, Maura P, Arosio P, Bou-Abdallah F.

Metallomics. 2019 Oct 16;11(10):1635-1647. doi: 10.1039/c9mt00154a.

PMID:
31513212
6.

The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells.

Asperti M, Cantamessa L, Ghidinelli S, Gryzik M, Denardo A, Giacomini A, Longhi G, Fanzani A, Arosio P, Poli M.

Pharmaceuticals (Basel). 2019 Sep 2;12(3). pii: E129. doi: 10.3390/ph12030129.

7.

Hepatic heparan sulfate is a master regulator of hepcidin expression and iron homeostasis in human hepatocytes and mice.

Poli M, Anower-E-Khuda F, Asperti M, Ruzzenenti P, Gryzik M, Denardo A, Gordts PLSM, Arosio P, Esko JD.

J Biol Chem. 2019 Sep 6;294(36):13292-13303. doi: 10.1074/jbc.RA118.007213. Epub 2019 Jul 17.

8.

Ferritin Light Chain Confers Protection Against Sepsis-Induced Inflammation and Organ Injury.

Zarjou A, Black LM, McCullough KR, Hull TD, Esman SK, Boddu R, Varambally S, Chandrashekar DS, Feng W, Arosio P, Poli M, Balla J, Bolisetty S.

Front Immunol. 2019 Feb 4;10:131. doi: 10.3389/fimmu.2019.00131. eCollection 2019.

9.

The role of heparin, heparanase and heparan sulfates in hepcidin regulation.

Asperti M, Denardo A, Gryzik M, Arosio P, Poli M.

Vitam Horm. 2019;110:157-188. doi: 10.1016/bs.vh.2019.01.008. Epub 2019 Feb 11. Review.

PMID:
30798810
10.

Ferritin exhibits Michaelis-Menten behavior with oxygen but not with iron during iron oxidation and core mineralization.

Bou-Abdallah F, Flint N, Wilkinson T, Salim S, Srivastava AK, Poli M, Arosio P, Melman A.

Metallomics. 2019 Apr 17;11(4):774-783. doi: 10.1039/c9mt00001a.

PMID:
30720039
11.

Potential Role of H-Ferritin in Mitigating Valvular Mineralization.

Sikura KÉ, Potor L, Szerafin T, Zarjou A, Agarwal A, Arosio P, Poli M, Hendrik Z, Méhes G, Oros M, Posta N, Beke L, Fürtös I, Balla G, Balla J.

Arterioscler Thromb Vasc Biol. 2019 Mar;39(3):413-431. doi: 10.1161/ATVBAHA.118.312191.

PMID:
30700131
12.

Sucrosomial® Iron Supplementation in Mice: Effects on Blood Parameters, Hepcidin, and Inflammation.

Asperti M, Gryzik M, Brilli E, Castagna A, Corbella M, Gottardo R, Girelli D, Tarantino G, Arosio P, Poli M.

Nutrients. 2018 Sep 21;10(10). pii: E1349. doi: 10.3390/nu10101349.

13.

Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines.

Codenotti S, Poli M, Asperti M, Zizioli D, Marampon F, Fanzani A.

J Cancer Res Clin Oncol. 2018 Sep;144(9):1717-1730. doi: 10.1007/s00432-018-2699-0. Epub 2018 Jul 3.

PMID:
29971532
14.

Ferritin is secreted via 2 distinct nonclassical vesicular pathways.

Truman-Rosentsvit M, Berenbaum D, Spektor L, Cohen LA, Belizowsky-Moshe S, Lifshitz L, Ma J, Li W, Kesselman E, Abutbul-Ionita I, Danino D, Gutierrez L, Li H, Li K, Lou H, Regoni M, Poli M, Glaser F, Rouault TA, Meyron-Holtz EG.

Blood. 2018 Jan 18;131(3):342-352. doi: 10.1182/blood-2017-02-768580. Epub 2017 Oct 26.

15.

Iron, Oxidative Damage and Ferroptosis in Rhabdomyosarcoma.

Fanzani A, Poli M.

Int J Mol Sci. 2017 Aug 7;18(8). pii: E1718. doi: 10.3390/ijms18081718. Review.

16.

Expression and characterization of the ferritin binding domain of Nuclear Receptor Coactivator-4 (NCOA4).

Gryzik M, Srivastava A, Longhi G, Bertuzzi M, Gianoncelli A, Carmona F, Poli M, Arosio P.

Biochim Biophys Acta Gen Subj. 2017 Nov;1861(11 Pt A):2710-2716. doi: 10.1016/j.bbagen.2017.07.015. Epub 2017 Jul 25.

PMID:
28754384
17.

Iron Oxidation and Core Formation in Recombinant Heteropolymeric Human Ferritins.

Mehlenbacher M, Poli M, Arosio P, Santambrogio P, Levi S, Chasteen ND, Bou-Abdallah F.

Biochemistry. 2017 Aug 1;56(30):3900-3912. doi: 10.1021/acs.biochem.7b00024. Epub 2017 Jul 18.

18.

Non-Anticoagulant Heparins Are Hepcidin Antagonists for the Treatment of Anemia.

Poli M, Asperti M, Ruzzenenti P, Naggi A, Arosio P.

Molecules. 2017 Apr 8;22(4). pii: E598. doi: 10.3390/molecules22040598. Review.

19.

Ferritin, cellular iron storage and regulation.

Arosio P, Elia L, Poli M.

IUBMB Life. 2017 Jun;69(6):414-422. doi: 10.1002/iub.1621. Epub 2017 Mar 27. Review.

20.

Mitochondrial ferritin deficiency reduces male fertility in mice.

Maccarinelli F, Regoni M, Carmona F, Poli M, Meyron-Holtz EG, Arosio P.

Reprod Fertil Dev. 2017 Sep;29(10):2005-2010. doi: 10.1071/RD16348.

PMID:
28063464

Supplemental Content

Loading ...
Support Center